Treatment of inflammatory diseases

Details for Australian Patent Application No. 2012216651 (hide)

Owner University of Chicago

Inventors Soliven, Betty C.

Agent Pizzeys

Pub. Number AU-A-2012216651

Parent 2007284337

Filing date 5 September 2012

Wipo publication date 20 September 2012

International Classifications

A61K 31/133 - having hydroxy groups, e.g. sphingosine

A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/4245 - Oxadiazoles

A61K 31/661 - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 25/00 Drugs for disorders of the nervous system

A61P 25/02 Drugs for disorders of the nervous system

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216651

20 September 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216652-Temporary roof anchor having shock absorbing means

2012216650-Wheelbarrow